Calcium channel blocker associated lower urinary tract symptoms in males: An Australian retrospective observational study

Quality in Primary Care

Volumn 19, Issue 4, 2011, Pages 223-231

  Hughes, Jeffery D ^a,c   Coles, Mark A ^a,b,c   Joyce, Andrew ^b  

^a CURTIN UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

Benign prostatic hyperplasia; Calcium channel blockers; Lower urinary tract symptoms; Male; Quality of life

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

AGED; ARTICLE; AUSTRALIA; CHEMICALLY INDUCED DISORDER; COMORBIDITY; HUMAN; MALE; MICTURITION DISORDER; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDY; TIME;

AGED; AGED, 80 AND OVER; AUSTRALIA; CALCIUM CHANNEL BLOCKERS; COMORBIDITY; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TIME FACTORS; URINATION DISORDERS;

EID: 80052746429     PISSN: 14791072     EISSN: 14791064     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Andersson K and Amer A. Urinary bladder contraction and relaxation: Physiology and pathophysiology. Physiological Reviews 2004;84:935-986 (Pubitemid 38823771)
2. Turner W and Brading A. Smooth muscle of the bladder in the normal and the diseased state: Pathophysiology, diagnosis and treatment. Pharmacology Therapeutics 1997;75:77-110. (Pubitemid 27521026)
3. Tewari A and Narayan P. Voiding dysfunction in men with lower urinary tract symptoms and benign prostatic hyperplasia. In: Urology for Primary Care Physicians. Philadelphia: WB Saunders, 1999, pp. 197-207.
4. Andersson K. Emptying against outflow obstruction: Pharmacology aspects. Scandinavian Journal of Nephrology 1997;184:77-84. (Pubitemid 27213781)
5. O'Reilly B., Kosaka A and Knight G. P2X receptors and their role in female idiopathic detrusor instability. The Journal of Urology 2002; 167:157-164 (Pubitemid 34024522)
6. Liu S., Volfson i, Horan P and Levin R. Effects of hypoxia, calcium, carbachol, atropine and tetrodotoxin on the filling of the in-vitro rabbit whole bladder. The Journal of Urology 1998;160:913-919 (Pubitemid 29479554)
7. Wein A. Bladder outlet obstruction: An overview. Advances in Experimental Medicine and Biology 1995;385:3-5.
8. Gosling J., Kung L., Dixon J., Horan P., Whitebeck C and Levin L. Correlation between the structure and function of the rabbit urinary bladder following partial outlet obstruction. The Journal of Urology 2000; 163:1349-1356 (Pubitemid 30169438)
9. Chacko S., DiSanto M., Wang Z., Zderic S and Wein A. Contractile protein changes in urinary bladder smooth muscle during obstruction-induced hypertrophy. Scandinavian Journal of Urology and Nephrology 1997;184: 67-76. (Pubitemid 27213780)
10. 2+ in human detrusor muscle via activation of muscarinic and purigenic receptors. British Journal of Urology 1996;78: 155.
11. Kajioka S., Nakayama S., McMurray G., Abe K and Brading A.F. Ca(2+) channel properties in smooth muscle cells of the urinary bladder from pig and human. European Journal of Pharmacology 2002;443:19-29. (Pubitemid 34603593)
12. 2+ channels in muscarinic receptor-mediated facilitation of ACh and noradrenaline release in the rat urinary bladder. Journal of Physiology 1997;499:645-654
13. Hedge S and Eglan R. Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder. Life Sciences 1999;64:419-428
14. Perlberg M and Caine M. Adrenergic response of bladder muscle in prostatic obstruction. Urology 1982;20:524-527
15. Saito M and Kondo A. Effects of verapamil on bladder instability induced by partial outflow obstruction in rat. International Urology and Nephrology 1998;30:543-552 (Pubitemid 29045669)
16. Christ G and Hodges S. Molecular mechanisms of detrusor and corporal myocyte contraction: Identifying targets for pharmacotherapy of bladder and erectile dysfunction. British Journal of Pharmacology 2006; 147: S41-S55. (Pubitemid 43239590)
17. Wegener J., Schulla V., Lee T. et al. An essential role of Cavl.2 L-type calcium channel for urinary bladder function. The FASEB Journal 2004; 18:1159-1161 (Pubitemid 39561556)
18. Nagle G., Radomski S., Brymer C., Mathiasen K., O'Rourke K and Thomlinson G. A randomised, double-blind, placebo controlled crossover trial of nimodipine in older persons with detrusor instability and urge incontinence. Journal ofUrology 2002;167:586-90.
19. Mattiasson A., Ekstrom B and Andersson K. Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity. Journal of Urology 1989;141: 174-177 (Pubitemid 19028863)
20. Frohlich G., Burmeister S., Wiedemann A and Bulitta M. Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test. Arzneimittel-Forschung 1998;48:486-491 (Pubitemid 28247635)
21. Faustini S., Salvinin A., Pizzi P, Conti M, Magistretti M and Vescovini R. Experimental study on the action of diltiazem on detrusor muscle and clinical evaluation in patients with detrusor hyperactivity. Arzneimittel-Forschung 1989;39:899-903. (Pubitemid 19204695)
22. Andersson K., Appell L and Cardozo L. The pharmacological treatment of urinary incontinence. British Journal of Urology 1999;84:923-947
23. 2+ on cholinergic, KCl and phorbol ester-mediated phosphoinositide turnover and guinea pig urinary bladder contraction. European Journal of Pharmacology 1991;195:273-279
24. Hamada K., Sasaki Y., Taniguchi N. et al. Anticholinergic and calcium antagonistic activities of NS-21 contribute to the inhibition of rat urinary bladder contractions. General Pharmacology: the Vascular System 1997;29:771-778 (Pubitemid 27475164)
25. Margot S., Damaser M., Kim K., Longhurst P., Wein A and Levin R. Calcium regulation of urinary bladder function. The Journal of Urology 1997;157:732-738 (Pubitemid 27026883)
26. Horvath G., Morvay Z., Kovacs M., Szilagyi A and Szikszay M. Drugs acting on calcium channels modulate the diuretic and micturition effects of dexmedetomidine in rats. Life Sciences 1996;59:1247-1257 (Pubitemid 26322922)
27. Brading A. Spontaneous activity of lower urinary tract smooth muscles: Correlation between ion channels and tissue function. Journal of Physiology 2006;570:13-22.
28. 2+ currents in freshly dispersed smooth muscle cells from the human proximal urethra. Journal of Physiology 2003;550:753-764
29. Barry M.J., Fowler F.J., O'Leary M. et al. Correlation of the American Urological Association Symptom Index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program Symptom Indexes. The Journal of Urology 1992; 148: 1558-1563
30. Hansen B., Mortensen S., Mensink H. et al. Comparison of the Danish prostatic symptom score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. British Journal of Urology 1998;81:36-41. (Pubitemid 28316495)
31. Barry M., Williford W., Chang Y. et al. Benign prostatic hyperplasia specific health status measures in clinical research: How much change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is perceptible to patients? The Journal of Urology 1995; 154:1770-1774
32. Barry M.J., Fowler F.J., Chang Y. et al. The American Urological Association symptom index: Does mode of administration affect its psychometric properties? Journal of Urology 1995;154:1056-1059
33. Netto N and De Lima M. The influence of patient education level on the International Prostatic Symptom Score. Journal of Urology 1995;154:97-99
34. Plante M., Coreos J and Gregorie L. The International Prostatic Symptom Score: Physician versus selfadministration in the quantification of symptomatology. Urology 1996;47:326-328
35. Rhodes T., Girman T., Jacobsen C. et al. Does the mode of questionnaire administration affect the reporting of urinary symptoms? Urology 1995;46:341-345
36. Barry M.J., Fowler F.J., O'Leary M.P. et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. Journal of Urology 1992; 148:1549-1557
37. Temml C., Brossner C., Schatzl G. et al. The natural history of lower urinary tract symptoms over five years. Urology 2003;43:374-380 (Pubitemid 36427456)
38. Triggle D. The pharmacology of ion channels: With particular reference to voltage-gated Ca2+ channels. European Journal of Pharmacology 1999;375:311-325 (Pubitemid 29317613)